+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Electrophoresis Equipment Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • April 2024
  • Region: Global
  • Expert Market Research
  • ID: 5960389

Global Electrophoresis Equipment Market Overview

The global electrophoresis equipment market size was valued at USD 3.2 billion in 2023, driven by intensive research and development activities across the globe. The market is projected to grow at a CAGR of 3.90% during the forecast period of 2024-2032, with the value likely to reach USD 5.27 billion by 2032.

Electrophoresis is a technique that separates molecules based on their size, charge, and shape in an electric field. Electrophoresis equipment consists of various components such as power supplies, gel tanks, electrodes, chambers, and accessories. Electrophoresis equipment is widely used in various fields such as biotechnology, pharmaceuticals, forensics, diagnostics, and research.

The growth of the market is driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic diseases, growing investments in research and development, and technological advancements in electrophoresis equipment. However, the market is also constrained by factors such as the high cost of equipment, lack of skilled personnel, and regulatory issues.

Global Electrophoresis Equipment Market Drivers and Constraints

  • The increasing demand for personalized medicine is one of the key drivers of the electrophoresis equipment market. Personalized medicine is an approach that tailors medical treatment to the individual characteristics of each patient, such as genetic, molecular, and environmental factors. Electrophoresis equipment is used to analyze the molecular profile of patients and identify biomarkers that can help in diagnosis, prognosis, and treatment of various diseases. Electrophoresis equipment can also help in drug discovery and development by screening potential drug candidates and evaluating their efficacy and safety.
  • The rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and infectious diseases is another major driver of the electrophoresis equipment market. Chronic diseases are the leading cause of death and disability worldwide, accounting for 71% of all deaths in 2019, according to the World Health Organization (WHO). Electrophoresis equipment is used to detect and monitor the biomarkers of chronic diseases and to evaluate the response to therapy. Electrophoresis equipment can also help in the development of novel therapeutics and vaccines for chronic diseases.
  • The growing investments in research and development (R&D) in the fields of biotechnology, pharmaceuticals, forensics, diagnostics, and research is a third key driver of the electrophoresis equipment market. R&D activities require high-quality and reliable electrophoresis equipment to perform various experiments and analyses. Electrophoresis equipment can help in the discovery and characterization of new molecules, genes, proteins, and biomarkers, as well as in the validation and quality control of products and processes. The increasing funding and support from governments, private organizations, and academic institutions for R&D activities is expected to boost the demand for electrophoresis equipment.
  • The technological advancements in electrophoresis equipment is a fourth key driver of the electrophoresis equipment market. The electrophoresis equipment market is witnessing various innovations and improvements in terms of performance, efficiency, accuracy, and convenience. Some of the examples of technological advancements in electrophoresis equipment are capillary electrophoresis, microfluidic electrophoresis, automated electrophoresis, and digital electrophoresis. These technologies offer advantages such as faster analysis, higher resolution, lower sample and reagent consumption, and better integration with other systems.
  • The high cost of electrophoresis equipment is one of the key constraints of the electrophoresis equipment market. Electrophoresis equipment is expensive to purchase, maintain, and operate, especially for small and medium-sized laboratories and research institutes. The high cost of electrophoresis equipment can limit its adoption and accessibility, especially in developing and underdeveloped regions. The high cost of electrophoresis equipment can also affect the profitability and competitiveness of the end-users.
  • The lack of skilled personnel is another key constraint of the electrophoresis equipment market. Electrophoresis equipment requires skilled and trained personnel to operate, interpret, and troubleshoot the results. The shortage of skilled personnel can affect the quality and reliability of the electrophoresis analysis and can lead to errors and delays. The lack of skilled personnel can also hamper the adoption and utilization of electrophoresis equipment, especially in emerging and remote areas.
  • The regulatory issues are a third key constraint of the electrophoresis equipment market. Electrophoresis equipment is subject to various regulations and standards that vary across regions and countries. The regulations and standards aim to ensure the safety, quality, and efficacy of the electrophoresis equipment and the products and processes that use it. However, the regulations and standards can also pose challenges and barriers for the electrophoresis equipment market, such as compliance costs, approval delays, and market restrictions.

Global Electrophoresis Equipment Market Trends and Developments

  • Technological Advancements: Innovations in electrophoresis equipment, such as the development of automated systems, high-throughput capabilities, and improved detection and analysis methods, are enhancing the efficiency and accuracy of experiments.
  • Growing Applications in Life Sciences: The use of electrophoresis in genomics, proteomics, and molecular diagnostics is expanding, driven by the increasing demand for precision medicine and personalized healthcare.
  • Rising Focus on Drug Discovery and Development: Electrophoresis is widely used in the pharmaceutical industry for drug development and quality control, contributing to the growth of the market.
  • Increased Adoption in Clinical Laboratories: The application of electrophoresis in clinical diagnostics, particularly for the separation and analysis of proteins and nucleic acids, is driving the adoption of these systems in clinical laboratories.
  • Integration with Other Technologies: The integration of electrophoresis equipment with other analytical techniques, such as mass spectrometry, is providing more comprehensive and detailed analyses, enhancing research outcomes.
  • Expansion in Emerging Markets: The electrophoresis equipment market is expanding in emerging economies due to increasing investments in research and development, growing healthcare infrastructure, and rising awareness about advanced analytical techniques.
  • Focus on Miniaturization and Portability: There is a trend towards miniaturization and the development of portable electrophoresis systems, which offer flexibility and convenience for researchers and clinicians.
  • Environmental and Safety Concerns: The market is also influenced by environmental and safety regulations related to the use and disposal of electrophoresis reagents and materials, prompting the development of safer and more sustainable alternatives.

Global Electrophoresis Equipment Market Segmentation

The global electrophoresis equipment market can be segmented based on product type, application, end-user, and region.

Market Breakup by Products

  • Electrophoresis Reagents
  • Electrophoresis Systems
  • Gel Documentation Systems
  • Electrophoresis Software

Market Breakup by Application

  • Diagnostic Application
  • Research Application
  • Quality Control & Process Validation

Market Breakup by End User

  • Hospital & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Electrophoresis Equipment Market Competitive Landscape

The global electrophoresis equipment market is highly competitive and fragmented, with the presence of numerous local and global players. The key players in the global electrophoresis equipment market are Thermo Fisher Scientific, Bio-RAD Laboratories, Merck Group, Agilent Technologies, Danaher Corporation, QIAGEN, Harvard Apparatus, Lonza Group Ltd., Perkin Elmer, Shimadzu Corporation, Biocompare, and Thistle Scientific. These players compete on the basis of product portfolio, innovation, quality, price, distribution, and customer service. The key strategies adopted by these players are product launches, mergers and acquisitions, partnerships and collaborations, and expansions and investments.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Electrophoresis Equipment Market Overview
3.1 Global Electrophoresis Equipment Market Historical Value (2017-2023)
3.2 Global Electrophoresis Equipment Market Forecast Value (2024-2032)
4 Global Electrophoresis Equipment Market Landscape*
4.1 Global Cardiac Pacemaker: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Electrophoresis Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Electrophoresis Equipment Market Segmentation (2017-2032)
6.1 Global Electrophoresis Equipment Market (2017-2032) by Products
6.1.1 Market Overview
6.1.2 Electrophoresis Reagents
6.1.3 Electrophoresis Systems
6.1.4 Gel Documentation Systems
6.1.5 Electrophoresis Software
6.2 Global Electrophoresis Equipment Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Diagnostic Application
6.2.3 Research Application
6.2.4 Quality Control & Process Validation
6.3 Global Electrophoresis Equipment Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospital & Diagnostic Centers
6.3.3 Pharmaceutical & Biotechnology Companies
6.3.4 Academic & Research Institutes
6.3.5 Others
6.4 Global Electrophoresis Equipment Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cardiac Pacemaker Market (2017-2032)
7.1 North America Cardiac Pacemaker Market (2017-2032) by Products
7.1.1 Market Overview
7.1.2 Electrophoresis Reagents
7.1.3 Electrophoresis Systems
7.1.4 Gel Documentation Systems
7.1.5 Electrophoresis Software
7.2 North America Cardiac Pacemaker Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Diagnostic Application
7.2.3 Research Application
7.2.4 Quality Control & Process Validation
7.3 North America Cardiac Pacemaker Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Cardiac Pacemaker Market (2017-2032)
8.1 Europe Cardiac Pacemaker Market (2017-2032) by Products
8.1.1 Market Overview
8.1.2 Electrophoresis Reagents
8.1.3 Electrophoresis Systems
8.1.4 Gel Documentation Systems
8.1.5 Electrophoresis Software
8.2 Europe Cardiac Pacemaker Market (2017-2032) by Applications
8.2.1 Market Overview
8.2.2 Diagnostic Application
8.2.3 Research Application
8.2.4 Quality Control & Process Validation
8.3 Europe Cardiac Pacemaker Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Quality Control & Process Validation
9 Asia Pacific Cardiac Pacemaker Market (2017-2032)
9.1 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Products
9.1.1 Market Overview
9.1.2 Electrophoresis Reagents
9.1.3 Electrophoresis Systems
9.1.4 Gel Documentation Systems
9.1.5 Electrophoresis Software
9.2 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Diagnostic Application
9.2.3 Research Application
9.2.4 Quality Control & Process Validation
9.3 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Quality Control & Process Validation
10 Latin America Cardiac Pacemaker Market (2017-2032)
10.1 Latin America Cardiac Pacemaker Market (2017-2032) by Products
10.1.1 Market Overview
10.1.2 Electrophoresis Reagents
10.1.3 Electrophoresis Systems
10.1.4 Gel Documentation Systems
10.1.5 Electrophoresis Software
10.2 Latin America Cardiac Pacemaker Market (2017-2032) by Applications
10.2.1 Market Overview
10.2.2 Diagnostic Application
10.2.3 Research Application
10.2.4 Quality Control & Process Validation
10.3 Latin America Cardiac Pacemaker Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Quality Control & Process Validation
11 Middle East and Africa Cardiac Pacemaker Market (2017-2032)
11.1 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Products
11.1.1 Market Overview
11.1.2 Electrophoresis Reagents
11.1.3 Electrophoresis Systems
11.1.4 Gel Documentation Systems
11.1.5 Electrophoresis Software
11.2 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Diagnostic Application
11.2.3 Research Application
11.2.4 Quality Control & Process Validation
11.3 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Quality Control & Process Validation
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Quality Control & Process Validation
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Thermo Fisher Scientific
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bio-RAD Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Merck Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Agilent Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 QIAGEN
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Harvard Apparatus
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lonza Group Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Perkin Elmer
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Shimadzu Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Biocompare
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Thistle Scientific
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
List not exhaustive!
18 Global Electrophoresis Equipment Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Thermo Fisher Scientific
  • Bio-RAD Laboratories
  • Merck Group Agilent Technologies
  • Danaher Corporation
  • QIAGEN
  • Harvard Apparatus
  • Lonza Group Ltd.
  • Perkin Elmer
  • Shimadzu Corporation
  • Biocompare
  • Thistle Scientific

Methodology

Loading
LOADING...